EUVIMEDEUVIMED entdecken
Crossref

Ara h 2 105‐124 ‐Specific TH2A Cells Drive Peanut Allergy in DRB1*15:01 Individuals: A Detailed Epitope Analysis

Rebecca A Gomez iD, Jue Hou iD, Vivian H Gersuk iD, I-Ting Chow iD, Mary L Farrington iD, David Robinson iD, William W Kwok iD

Clinical & Experimental Allergy · 2025

DOI: 10.1111/cea.70072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical & Experimental Allergy, 2025. Verfasst von Rebecca A Gomez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Immunology, Benaroya Research Institute, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Peanut Hypersensitivity, Th2 Cells, HLA-DRB1 Chains, Antigens, Plant. Die Arbeit nennt 100 Literaturangaben. Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The IgE‐mediated CD4 T‐cell response to peanut ( Arachis hypogaea ) is heterogeneous, yet TH2 cells remain central drivers of pathology. This study aimed to dissect this complexity at the epitope level by focusing on the HLA‐DRB1*15:01–DRB5*01:01 haplotype. Specifically, we examined how distinct epitope‐specific T‐cell subsets shape the immunological landscape of peanut allergy in peanut‐allergic (PA) versus non‐peanut‐allergic (NPA) individuals.

Methods

Using in vitro and ex vivo MHC‐II tetramer approaches, the phenotype, frequency, function, and transcriptome of CD4 T‐cell responses to novel Ara h epitopes were assessed. Bulk RNA sequencing further characterised these T cells, allowing identification of subsets associated with TH2 polarisation in PA individuals.

Results

Eleven HLA‐DRB1*15:01 and DRB5*01:01‐restricted epitopes were identified in Ara h 1, 2, 3, 6, 7, and 8 using tetramer‐guided epitope mapping on cell lines, followed by ex vivo validation in peripheral blood. T‐cell phenotype was epitope‐dependent, with a distinct TH2A population specific to the epitope Ara h 2 105–124 (Ara h 2 p14) detected only in PA donors. These TH2A cells were phenotypically and transcriptionally distinct, marked by high CRTH2/CD161, low CD27, IL‐5 production, and gene enrichment in cytokine signalling and lipid metabolism. Other epitope‐specific T‐cell subsets displayed more heterogeneous gene profiles related to immune activation, differentiation, and antigen presentation, underscoring the complexity of peanut‐specific responses even within a single HLA haplotype.

Conclusion

These findings reveal that the strong TH2 bias in DRB1*15:01‐DRB5*01:01 PA individuals arises from a distinct subset of Ara h 2 p14‐specific TH2A cells characterised by a specialised metabolic and cytokine signalling program. At the same time, the functional diversity observed in non‐Ara h 2 p14 subsets highlights the potential for leveraging these populations in tolerance‐promoting therapies. Understanding the epitope‐level heterogeneity of peanut‐specific T‐cells provides insight into the epitope‐specific mechanisms driving peanut allergy and has potential implications for therapeutic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peanut HypersensitivityTh2 CellsHLA-DRB1 ChainsAntigens, PlantEpitopes, T-LymphocytePlant ProteinsGlycoproteinsHumansFemaleMaleEpitope MappingAdultAllergensArachis

Stichwörter der Autor:innen

Ara h 2CD4+ T‐cellsTH2A cellscellular metabolismpeanut allergy

Substanzen

HLA-DRB1 ChainsAntigens, PlantEpitopes, T-LymphocytePlant ProteinsHLA-DRB1*15:01 antigenGlycoproteinsAllergens

Autor:innen und Institutionen

  • Center for Translational Immunology, Benaroya Research Institute, Seattle, Washington, USA.
  • Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Center for Systems Immunology, Benaroya Research Institute, Seattle, Washington, USA.
  • Immune Medicine Division, Adaptive Biotechnologies, Seattle, Washington, USA.
  • Allergy and Immunology, Virginia Mason Franciscan Health, Seattle, Washington, USA.
  • Department of Medicine, University of Washington, Seattle, Washington, USA.

ORCID-Profile: Rebecca A Gomez, Jue Hou, Vivian H Gersuk, I-Ting Chow, Mary L Farrington, David Robinson, William W Kwok

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Gomez, R. A., Hou, J., Gersuk, V. H., Chow, I. T., Farrington, M. L., Robinson, D., & Kwok, W. W. (2025). Ara h 2 105‐124 ‐Specific TH2A Cells Drive Peanut Allergy in DRB1*15:01 Individuals: A Detailed Epitope Analysis. Clinical & Experimental Allergy. https://doi.org/10.1111/cea.70072

Vancouver

Gomez RA, Hou J, Gersuk VH, Chow IT, Farrington ML, Robinson D, et al. Ara h 2 105‐124 ‐Specific TH2A Cells Drive Peanut Allergy in DRB1*15:01 Individuals: A Detailed Epitope Analysis. Clinical & Experimental Allergy. 2025. doi:10.1111/cea.70072

BibTeX
@article{Gomez2025,
  author = {Gomez, Rebecca A and Hou, Jue and Gersuk, Vivian H and Chow, I-Ting and Farrington, Mary L and Robinson, David and Kwok, William W},
  title = {Ara h 2 105‐124 ‐Specific TH2A Cells Drive Peanut Allergy in DRB1*15:01 Individuals: A Detailed Epitope Analysis},
  journal = {Clinical & Experimental Allergy},
  year = {2025},
  doi = {10.1111/cea.70072}
}
Kostenlos starten →